Literature DB >> 10871338

Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice.

D M Weinstein1, M J Mihm, J A Bauer.   

Abstract

Selective cardiotoxicity of doxorubicin remains a significant and dose-limiting clinical problem. The mechanisms involved have not been fully defined but may involve the production of reactive oxygen species and/or alteration of cardiac energetics. Here, we tested the hypotheses that doxorubicin causes left ventricular dysfunction in mice and is associated with dysregulation of nitric oxide in cardiac tissue, leading to the accumulation of 3-nitrotyrosine (a biomarker of peroxynitrite formation). Animals were dosed with doxorubicin (20 mg/kg i.p.), and left ventricular performance was assessed in vivo using M-mode and Doppler echocardiography. Five days after doxorubicin administration, left ventricular fractional shortening, cardiac output, and stroke volume parameters were significantly reduced relative to control values (30.0 +/- 3.6 versus 46.1 +/- 1. 6%, 8.9 +/- 0.9 versus 11.5 +/- 0.6 ml/min, and 21.2 +/- 0.1 versus 29.5 +/- 0.1 microl for doxorubicin versus control, P <.05). Statistically significant (P <.05) increases in the immunoprevalence of myocardial inducible nitric oxide synthase (33 +/- 18 versus 9 +/- 2%, via quantitative image analysis) and 3-nitrotyrosine formation (56 +/- 24 versus 0.3 +/- 0.4%) were also observed after doxorubicin. Correlation analyses revealed a highly significant inverse relationship between left ventricular fractional shortening and cardiac 3-nitrotyrosine immunoprevalence (P <.01). No such relationship was observed for inducible nitric oxide synthase. Western blot analyses of cardiac myofibrillar fractions revealed extensive nitration of an abundant 40-kDa protein, shown to be the myofibrillar isoform of creatine kinase. These data demonstrate that alteration of cardiac nitric oxide control and attendant peroxynitrite formation may be an important contributor to doxorubicin-induced cardiac dysfunction. Furthermore, nitration of key myofibrillar proteins and alteration of myocyte energetics are implicated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871338

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  52 in total

1.  Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase.

Authors:  Michael J Mihm; Fushun Yu; David M Weinstein; Peter J Reiser; John Anthony Bauer
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 2.  Cardiovascular redox and ox stress proteomics.

Authors:  Vikas Kumar; Timothy Dean Calamaras; Dagmar Haeussler; Wilson Steven Colucci; Richard Alan Cohen; Mark Errol McComb; David Pimentel; Markus Michael Bachschmid
Journal:  Antioxid Redox Signal       Date:  2012-08-10       Impact factor: 8.401

3.  Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury.

Authors:  Partha Mukhopadhyay; Bėla Horváth; Mohanraj Rajesh; Shingo Matsumoto; Keita Saito; Sándor Bátkai; Vivek Patel; Galin Tanchian; Rachel Y Gao; Benjamin F Cravatt; György Haskó; Pál Pacher
Journal:  Free Radic Biol Med       Date:  2010-11-09       Impact factor: 7.376

Review 4.  Toxicological and pathophysiological roles of reactive oxygen and nitrogen species.

Authors:  Ruth A Roberts; Robert A Smith; Stephen Safe; Csaba Szabo; Ronald B Tjalkens; Fredika M Robertson
Journal:  Toxicology       Date:  2010-07-17       Impact factor: 4.221

5.  Doxorubicin pathways: pharmacodynamics and adverse effects.

Authors:  Caroline F Thorn; Connie Oshiro; Sharon Marsh; Tina Hernandez-Boussard; Howard McLeod; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-07       Impact factor: 2.089

6.  Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice.

Authors:  Chu Chang Chua; Jinping Gao; Ye-Shih Ho; Xingshun Xu; I-Chun Kuo; Kaw-Yan Chua; Hong Wang; Ronald C Hamdy; John C Reed; Balvin H L Chua
Journal:  Cardiovasc Res       Date:  2008-09-18       Impact factor: 10.787

Review 7.  Mitochondrial superoxide dismutase--signals of distinction.

Authors:  Sumitra Miriyala; Aaron K Holley; Daret K St Clair
Journal:  Anticancer Agents Med Chem       Date:  2011-02       Impact factor: 2.505

Review 8.  Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.

Authors:  Pál Pacher; Irina G Obrosova; Jon G Mabley; Csaba Szabó
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

9.  Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.

Authors:  Partha Mukhopadhyay; Mohanraj Rajesh; Sándor Bátkai; Yoshihiro Kashiwaya; György Haskó; Lucas Liaudet; Csaba Szabó; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

10.  CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.

Authors:  Partha Mukhopadhyay; Mohanraj Rajesh; Sándor Bátkai; Vivek Patel; Yoshihiro Kashiwaya; Lucas Liaudet; Oleg V Evgenov; Ken Mackie; György Haskó; Pál Pacher
Journal:  Cardiovasc Res       Date:  2009-11-26       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.